Immix Biopharma, Inc. IMMX Lessee Operating Lease Liability Payments Due Year Five And Thereafter
Lessee Operating Lease Liability Payments Due Year Five And Thereafter at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept IMMX:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter.
The official record: Immix Biopharma, Inc.’s 10-K/A, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s lessee operating lease liability payments due year five and thereafter.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s lessee operating lease liability payments due year five and thereafter?
- Immix Biopharma, Inc. (IMMX) reported lessee operating lease liability payments due year five and thereafter of $564.34K in Q4 2025.
- What does lessee operating lease liability payments due year five and thereafter mean?
- This metric quantifies the total future cash obligations for operating leases that are scheduled to be paid five years or more after the balance sheet date. It reflects the long-term fixed financial commitments associated with leased facilities or equipment. Monitoring this helps investors evaluate the company's long-term liquidity risk and fixed cost structure.